Fungal Infections
RSSArticles
-
COVID-19 Exacerbated Antimicrobial Resistance
CDC report indicates related infections and deaths rose 15% in hospitals in 2020.
-
Oteseconazole Capsules (Vivjoa)
The FDA has approved the first drug to reduce recurrent vulvovaginal candidiasis.
-
Infectious Disease Alert Updates
Delayed HIV Diagnosis with Injectable PrEP; Fatal Wave of COVID-Associated Mucormycosis
-
A Probiotic May Cause Sepsis and Death
Saccharomyces boulardii is a probiotic yeast that may cause fungemia and other fungal infections.